AstraZeneca has agreed to pay up to $1.5 billion for global rights to Dizal Pharmaceutical's targeted lung cancer drug Sunvozertinib, emphasizing global interest in Chinese oncology assets.
Williams··2 min read
Indian researchers have developed a "placenta-on-chip" technology to simulate maternal-fetal physiological interactions, aiming to improve drug safety assessments; the technology currently awaits further peer-reviewed validation.
Williams··2 min read
Mantis Biotech is using AI and synthetic datasets to create 'digital twins' of the human body, aimed at solving data availability problems in medical research.
Williams··2 min read
Stealth startup R3 Bio has revealed controversial research plans to create "non-sentient" monkey organ sacks. The move has triggered global debate regarding the ethical boundaries of synthetic biology and the adequacy of current regulatory frameworks.
Williams··2 min read
Researchers have successfully maintained a human uterus outside the body for the first time. This breakthrough offers new potential for reproductive medicine and transplantation but raises significant questions about ethics, legal regulation, and the definition of human life.
Williams··2 min read